HLA-DQB1 genotypes and islet cell autoantibodies against GAD65 and IA-2 in relation to development of diabetes post partum in women with gestational diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 95, Issue 2, 2012, Pages 260-264

  Papadopoulou, Anastasia ^a   Lynch, Kristian F ^a,b   Anderberg, Eva ^a   Landin Olsson, Mona ^a   Hansson, Ida ^a   Agardh, Carl David ^a   Lernmark, åke ^a   Berntorp, Kerstin ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Genes; Hyperglycemia; Pregnancy

Indexed keywords

ANTIGEN; GLUCOSE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; HLA DQB1 ANTIGEN; INSULINOMA ANTIGEN 2; INSULINOMA ANTIGEN 2 AUTOANTIBODY; PANCREAS ISLET CELL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAPILLARY BLOOD; CONTROLLED STUDY; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLUCOSE BLOOD LEVEL; HLA DQB1 GENE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PATHOGENESIS; PREDICTION; PREGNANCY DIABETES MELLITUS; PUERPERIUM; REFERENCE VALUE;

ADULT; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; DIABETES, GESTATIONAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSE TOLERANCE TEST; GLUTAMATE DECARBOXYLASE; HLA-DQ BETA-CHAINS; HUMANS; ISLETS OF LANGERHANS; POSTPARTUM PERIOD; PREGNANCY; SWEDEN;

EID: 84856337975     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.10.037     Document Type: Article

References (19)

1. Buchanan T.A., Xiang A., Kjos S.L., Watanabe R. What is gestational diabetes?. Diabetes Care 2007, 30:S105-S111.
2. Kim C., Newton K.M., Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002, 25:1862-1868.
3. Metzger B.E., Buchanan T.A., Coustan D.R., de Leiva A., Dunger D.B., Hadden D.R., et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007, 30:S251-S260.
4. Lapolla A., Dalfrà M.G., Fedele D. Diabetes related autoimmunity in gestational diabetes mellitus: is it important?. Nutr Metab Cardiovasc Dis 2009, 19:674-682.
5. Ferber K.M., Keller E., Albert E.D., Ziegler A.G. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes. J Clin Endocrinol Metab 1999, 84:2342-2348.
6. Anderberg A., Källén K., Berntorp K. The impact of gestational diabetes mellitus on pregnancy outcome comparing different cut-off criteria for abnormal glucose tolerance. AOGS 2010, 89:1532-1537.
7. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Report of a WHO consultation. World Health Organization; 1999.
8. Burnett R.W., D'Orazio P., Fogh-Andersen N., Kuwa K., Külpmann W.R., Larsson L., et al. IFCC recommendation on reporting results for blood glucose. Clin Chim Acta 2001, 307:205-209.
9. World medical association declaration of Helsinki. Ethical principles for medical research involving human subjects. Adopted by the 59th WMA general assembly, Seoul, October 2008.
10. Larsson H.E., Lynch K., Lernmark B., Nilsson A., Hansson G., Almgren P., et al. Diabetes-associated HLA genotypes affect birthweight in the general population. Diabetologia 2005, 48:1484-1491.
11. Delli A.J., Lindblad B., Carlsson A., Forsander G., Ivarsson S.A., Ludvigsson J. Type 1 diabetes patients born to immigrants to Sweden increase their native diabetes risk and differ from Swedish patients in HLA types and islet autoantibodies. Pediatr Diabetes 2010, 11:513-520.
12. Lynch K.F., Lernmark B., Merlo J., Cilio C.M., Ivarsson S.A., Lernmark A. Cord blood islet autoantibodies and seasonal association with the type 1 diabetes high-risk genotype. J Perinatol 2008, 28:211-217. Diabetes Prediction in Skåne (DiPiS) Study Group.
13. Papadopoulou A., Lynch K.F., Shaat N., Nilsson A., Lernmark B., Berntorp K., et al. The type 1 diabetes protective HLA DQB1*0602 allele is less frequent in gestational diabetes mellitus. Diabetologia 2009, 52:1339-1342.
14. Shaat N., Ekelund M., Ivarsson S., Nilsson A., Perfekt R., et al. Genotypic and phenotypic differences between Arabian and Scandinavian women with gestational diabetes mellitus. Diabetologia 2004, 47:878-884.
15. Ekelund M., Shaat N., Almgren P., Groop L., Berntorp K. Prediction of postpartum diabetes in women with gestational diabetes mellitus. Diabetologia 2010, 53:452-457.
16. åberg A., Jönsson E., Eskilsson I., Landin-Olsson M., Frid A.H. Predictive factors of developing diabetes mellitus in women with gestational diabetes. Acta Obstet Gynecol Scand 2002, 81:11-16.
17. Nilsson C., Ursing D., Törn C., åberg A., Landin-Olsson M. Presence of GAD antibodies during gestational diabetes mellitus predicts type 1 diabetes. Diabetes Care 2007, 30:1968-1971.
18. Graham J., Kockum I., Sanjeevi C.B., Landin-Olsson M., Nyström L., Sundkvist G., et al. Negative association between type 1 diabetes and HLA DQB1*0602-DQA1*0102 is attenuated with age at onset. Eur J Immunogenet 1999, 26:117-127.
19. Damm P., Kühl C., Buschard K., Jakobsen B.K., Svejgaard A., Sodoyez-Goffaux F., et al. Prevalence and predictive value of islet cell antibodies and insulin autoantibodies in women with gestational diabetes. Diabet Med 1994, 11:558-563.